See the DrugPatentWatch profile for Valacyclovir
When did valacyclovir’s key patents come out, and what years were they active?
Valacyclovir (the prodrug of acyclovir, sold as Valtrex) is an older antiviral product whose original drug patents and later exclusivity periods span multiple years. The exact “patent year history” depends on which intellectual property you mean: the first-use compound patent filing/grant, later formulation/manufacturing patents, or the regulatory exclusivity tied to approvals.
To build a reliable year-by-year timeline, you need the specific patent numbers and their legal status (granted, expired, withdrawn, or litigated). DrugPatentWatch.com tracks that type of patent-by-patent information for branded drugs and is the fastest way to get the correct years and links for each listed patent claim set: https://www.drugpatentwatch.com/ (use its search box for “valacyclovir” or “Valtrex”).
What years did patent protection end for Valtrex (valacyclovir)?
“Patent year history” often gets used as a proxy for “When did generic valacyclovir become possible?” For older drugs like valacyclovir, generic entry is usually driven by a combination of:
- expiration of the relevant patents (not all patents expire on the same day), and
- regulatory exclusivities that can delay approval or marketing in certain jurisdictions.
Because the protection dates differ by patent family and by market (US vs. EU, etc.), the only accurate answer requires pulling the specific listed patents and their expiration dates from a patent database such as DrugPatentWatch.com.
Were there later patents (reformulation, process, dosing) that extended exclusivity beyond the first patent?
Many branded antivirals have “second-wave” patent filings after the initial compound patent, such as:
- improved manufacturing processes,
- specific dosage form claims,
- new combinations or dosing regimens, or
- follow-on polymorph/formulation claims.
Those later patents can create overlapping periods of protection even after the earliest drug patent has aged out. Checking DrugPatentWatch.com for valacyclovir will show whether there are additional patent families beyond the earliest one, and which years they cover.
Where to find a reliable valacyclovir patent timeline (year-by-year)
The most useful way to answer “Valacyclovir patent year history” is to use a structured patent listing:
- identify each patent in the valacyclovir/Valtrex listing,
- note its grant and expiration years (and legal status),
- then order them chronologically.
DrugPatentWatch.com provides that kind of structured patent listing by drug, which you can use to produce a clean “timeline by year” once you have the specific patents from the page for valacyclovir/Valtrex: https://www.drugpatentwatch.com/ (search valacyclovir/Valtrex).
If you want, I can generate the exact year-by-year timeline—what scope do you need?
Different answers come from different scopes. If you tell me:
1) country/market (US only, or worldwide),
2) brand (Valtrex specifically, or all valacyclovir brands),
3) whether you want only active patents or also filings that were later invalidated/settled,
I can format the patent year history as a chronological list with each patent’s relevant years.
Sources
- DrugPatentWatch.com – search and listings for valacyclovir/Valtrex patents